Abstract
Diffusion chambers include a diversity of planar and tubular configurations, including flat sheets, disks, hollow fibers and wide-bore tubes.1–5 Although various device designs have been studied for nearly half a century, these experiments have been performed mainly in rodents, and only recently has any progress with the diffusion chamber technique been reported in large animals.6 In the late 1940s/early 1950s, Algire and coworkers7–9 first transplanted cells enclosed in Millipore diffusion chambers into mice, in order to study the mechanisms of cellular immune rejection. The viability of the implanted tissue was severely compromised by fibrous overgrowth of the extracapillary-situated chambers. Subsequent studies with islet allografts and xenografts in rodents were equally discouraging 10–17 Although partial or transient normoglycemia was achieved in some studies, the outer membrane surface was rapidly covered by fibrosis, and islet survival was not observed after a few weeks of transplantation. Furthermore, Theodorou and Howell18 investigated the in vitro glucoseinsulin transfer kinetics of this kind of macroencapsulation device and found that the transit half-time of insulin (almost an hour) was less than optimal for physiologic regulation of blood glucose concentrations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Colton CK 1995. Implantable biohybrid artificial organs. Cell Transplant 4:415–436.
Lanza RP, Hayes JL, Chick WL. 1996. Encapsulated cell technology. Nature Biotechnology 14:1107–1111.
Mikos AG, Papadaki MG, Kouvroukoglou S, Ishaug SL, Thomson RC. 1994. Mini-review: Islet transplantation to create a bioartificial pancreas. Biotech Bioeng 43:673–677.
Zielinski BA, Goddard MB, Lysaght MJ. 1997. Immunoisolation. In: Principles of tissue engineering (Lanza RP, Langer R and Chick WL, eds) pp. 321–326,San Diego: Academic Press.
Lanza RL, Chick WL. 1997. Transplantation of encapsulated cells and tissues. Surgery 121:1–9.
Lanza RP, Borland KM, Lodge P, et al. 1992. Treatment of severely diabetic, pancreatectomized dogs using a diffusion-based hybrid pancreas. Diabetes 41:886.
Algire GH, Legallais FY. 1949. Recent developments in the transplant chamber technique as adapted to the mouse. J Natl Cancer Inst 10:225–253.
Algire GH, Weaver JM, Prehn RT. 1954. Growth of cells in vivo in diffusion chambers. I. Survival of homografts in immunized mice. J Natl Cancer Inst 15:493–507.
Prehn RT, Weaver JM, Algire GH. 1954. The diffusion-chamber technique applied to a study of the nature of homograft resistance. J Natl Cancer Inst 15:509–17.
Garvey JF, Morris PJ, Finch DR, et al. 1979. Experimental pancreas transplantation. Lancet 971–972.
Theodorou NA, Vrbova H, Tyhurst M, Howell SL. 1980. Problems in the use of polycarbonate diffusion chambers for syngeneic pancreatic islet transplantation in rats. Diabetologia 18:313–317.
Strautz RL. 1970. Studies of hereditary-obese mice (ob/ob) after implantation of pancreatic islets in Millipore filter capsules. Diabetologia 6:306–312.
Weber C, Weil R, Mclntosh R, et al. 1975. Xenotransplantation of porcine islets into hyperglycEmie rats. Surgery 77:208–215.
Buschard K. 1975. Cultivation of islets of Langerhans in Millipore chambers in vivo. Horm Metab Res 7:441–442.
Jolley WB, Hinshaw DB, Call TW, Alverel LS. 1977. Xenogeneic pancreatic islet transplantation in proteolytic enzyme bonded diffusion chambers in diabetic rats. Transplant Proc 9:363–365.
Andersson A. 1979. Survival of pancreatic islet allografts. Lancet 2:585.
Valente U, Ferro M, Campisi C, et al. 1981. Islet transplantation by means of artificial membrane chambers in diabetic recipients. Artif Organs 5(Suppl):780–783.
Theodorou NA, Howell SL. 1979. An assessment of diffusion chambers for use in pancreatic islet cell transplantation. Transplantation 27:350–352.
Brauker JH, Carr-Brendel VE, Martinson LA, et al. 1995. Neovascularization of synthetic membranes directed by membrane microarchitecture. J Biomed Mat Res 29:1517.
Brauker J, Martinson LA, Young SK, and Johnson RC. 1996. Local inflammatory response around diffusion chambers containing xenografts. Transplantation 61:1671–1677.
Dionne K, Scharp D, Lysaght MJ, Hegre O, Lacy P. 1994 Macroencapsulation of islets for the treatment of diabetes. In: Pancreatic islet transplantation Volume III: Immunoisolation of pancreatic islets (Lanza RP and Chick WL, eds) pp. 119–131, Austin, Texas: RG Landes Company.
Suzuki K, Bonner-Weir S, Hollister J, Weir GC. 1996. A method for estimating number and mass of islets transplanted within a membrane device. Cell Transplant 5:613–625.
Loudovaris T, Mandel TE, Charlton B. 1996. CD4+ T cell mediated destruction of xenografts within cellimpermeable membranes in the absence of CD8+ T cells and B cells. Transplantation 61:1678–1684.
Woodward CL. 1982. How fibroblasts and giant cells encapsulate implants: Considerations in design of glucose sensors. Diabetes Care 5:278.
Altman JJ, Houlbert D, Bruzzo F, et al. 1982. Implantation of semipermeable hollow fibers to prevent immune rejection of transplanted pancreatic islets. In: Islet-pancreas-transplantation and artificial pancreas (Federlin K, Pfeiffer E, Raptis S, eds) New York: Thieme-Stratton.
Altman JJ, Houlbert D, Callard P, et al. 1986. Longterm plasma glucose normalization in experimental diabetic rats with microencapsulated implants of benign human insulinomas. Diabetes 35:625.
Archer J, Kaye R, Matter G. 1980. Control of streptozotocin diabetes in Chinese hamsters by cultured mouse islet cells without immunosuppression. J Surg Res 28:77.
Icard P, Penfornis F, Gotheil C, et al 1990. Tissue reaction to implanted bioartificial pancreas in pigs. Transplant Proc 22:724.
Lanza RP, Butler DH, Borland KM et al 1991. Xenotransplantation of canine, bovine, and porcine islets in diabetic rats without immunosuppression. Proc Natl Acad Sei USA 88:11100.
Lanza RP, Butler DH, Borland KM, et al 1992. Successful xenotransplantation of a diffusion-based biohybrid artificial pancreas: A study using canine, bovine, and porcine islets. Transplant Proc 24:669.
Lanza RP, Borland KM, Staruk JE, et al 1992. Transplantation of encapsulated canine islets into spontaneously diabetic BB/Wor rats without imunosuppression. Endocrinology 131:637.
Lanza RP, Beyer AM, Staruk JE, Chick WL. 1993. Biohybrid artificial pancreas: Longterm function of discordant islet xenografts in streptozotocin diabetic rats. Transplantation 56:1067.
Theodorou NA, Vrbova H, Tyhurst M, et al 1979. An assessment of diffusion chambers for use in pancreatic islet cell transplantation. Transplantation 27:350.
Andersson A. Survival of pancreatic islet allografts 1979. Lancet 2:585.
Kraegen EW, Chisholm DJ, MacNamara ME. 1981. Timing of insulin delivery with meals. Horm Metab Res 13:365.
Lanza RP, Lodge P, Borland KM, et al 1993. Transplantation of islet allografts using a diffusion-based biohybrid artificial pancreas: long-term studies in diabetic, pancreatectomized dogs. Transplant Proc 25:978.
Lanza RP, Beyer AM, Chick WL. 1994. Xenogeneic humoral responses to islets transplanted in biohybrid diffusion chambers. Transplantation 57:1371.
Lanza RP, Kühtreiber WM, Beyer A, et al 1994. Humoral response to encapsulated islets. Transplant Proc 26:3346.
Theofilopoulos AN, Dixon FJ. 1979. The biology and detection of immune complexes. Adv Immunol 28:89.
Wilson CB, Dixon FJ. 1971. Quantification of acute and chronic serum sickness in the rabbit. J Exp Med 134:7S.
Benacerraf B, Sebestyen M, Cooper HS. 1959. The clearance of antigen-antibody complexes from the blood by the reticulo-endothelial system. J Immunol 82:131.
Cochrane CG, Koffler D. 1973. Immune complex disease in experimental animals and man. Adv Immunol 16:185.
Kijlstra A, Van Der Lelij A, Knutson DW, et al 1978. The influence of phagocyte function on glomerular localization of aggregated IgG in rats. Clin Exp Immunol 32:207.
Haakenstad AO, Mannik M. 1974. Saturation of the reticuloendothelial system with soluble immune complexes. J Immunol 112:1939.
Austen KF. 1991. Diseases of immediate type hypersensitivity. In: Harrison’s principles of internal medcine, 12th edition (Wilson JD, Braunwald KJ, Isselbacher KJ, eds) New York: McGraw-Hill, p. 1422.
Sasazuki T, Kohno Y, Iwamoto I, et al 1978. Association between an HLA haplotype and low responsiveness to tetanus toxiod in man. Nature 272:359.
de Vries RP, Kreeftenberg HG, Loggen HG, et al 1977. In vitro immune responsiveness to vaccinea virus and HLA. N Engl J Med 297:692.
Christiansen FT, Hawkins BR, Dawkins RL. 1978. Immune function in ankylosing spondylitics and their relatives: influence of disease and HLA B27. Clin Exp Immunol 33:270.
Scharp DW, Swanson CJ, Olack BJ, et al 1994. Protection of encapsulated human islets implanted without immunosuppression in patients with type I or type II diabetes and in nondiabetic control subjects. Diabetes 43:1167–1170.
Sagen J. 1996. Chromaffin cell transplantation. In: 1996/97 Yearbook of Cell and Tissue Transplantation (Lanza RP, Chick WL, eds) Dordrecht, The Netherlands: Kluwer Academic Press.
Aebischer P, Buchser E, Joseph JM, et al 1994. Transplantation in humans of encapsulated xenogeneic cells without immunosuppression. Transplantation 58:1275–7.
Ezzell C. 1995. Tissue engineering and the human body shop: encapsulated-cell transplants enter the clinic. J NIH Research 7:47–51.
Sendtner M, Schmalbruch H, Stockli KA, et al 1992. Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant neuropathy. Nature 358:502–4.
Sagot Y, Tan SA, Baetge E, et al 1995. Polymer encapsulated cell lines genetically engineered to release ciliary neurotrophic factor can slow down progressive motor neuropathy in the mouse. Eur J Neurosci 7:1313–22.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Lanza, R.P. (1999). Diffusion Chambers. In: Kühtreiber, W.M., Lanza, R.P., Chick, W.L. (eds) Cell Encapsulation Technology and Therapeutics. Birkhäuser, Boston, MA. https://doi.org/10.1007/978-1-4612-1586-8_15
Download citation
DOI: https://doi.org/10.1007/978-1-4612-1586-8_15
Publisher Name: Birkhäuser, Boston, MA
Print ISBN: 978-1-4612-7205-2
Online ISBN: 978-1-4612-1586-8
eBook Packages: Springer Book Archive